Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2500081	注射用奥马珠单抗α	omalizumab	Lyophilized	Biological Products	Supplementary Application	2025-04-16	Taizhou Maibotaike Pharmaceutical Co Ltd	view
CXSL2300377	注射用奥马珠单抗α	omalizumab	Lyophilized	Biological Products(3.4)	New Drug Application	2023-05-27	Taizhou Maibotaike Pharmaceutical Co Ltd	view
CYSB2500027	注射用奥马珠单抗α	omalizumab	Lyophilized	Biological Products	Supplementary Application	2025-01-25	Taizhou Maibotaike Pharmaceutical Co Ltd	view
CYSB2500028	注射用奥马珠单抗α	omalizumab	Lyophilized	Biological Products	Supplementary Application	2025-01-25	Taizhou Maibotaike Pharmaceutical Co Ltd	view
CYSB2500080	注射用奥马珠单抗α	omalizumab	Lyophilized	Biological Products	Supplementary Application	2025-04-16	Taizhou Maibotaike Pharmaceutical Co Ltd	view
CXSL2300378	注射用奥马珠单抗α	omalizumab	Lyophilized	Biological Products(3.4)	New Drug Application	2023-05-27	Taizhou Maibotaike Pharmaceutical Co Ltd	view